Daiichi Sankyo Nordics ApS
Global pharmaceutical company developing innovative oncology and cardiovascular medical treatments.
Yleiskatsaus
- 29
- Työntekijät
- Tuntematon
- Liikevaihto
- 2018
- Perustettu
Avainpäättäjät
Mitsuhiro Matsumoto
Outside Audit & Supervisory Board Member (Independent Auditor)
Shizuko Ueno
Director, Executive Officer, Head of Japan Business Unit and Head of Medical Affairs Division, Japan Business Unit
Yo Honma
Outside Director (Independent Director), Chairperson of the Compensation Committee
Yukiko Imazu
Outside Audit & Supervisory Board Member (Independent Auditor)
+16 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Daiichi Sankyo is a global, innovative pharmaceutical company dedicated to discovering, developing, and delivering new standards of care to improve patient lives worldwide. With a history spanning over 120 years, the company focuses on addressing high unmet medical needs, particularly in the fields...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- APS
- ALV-numero
- DK39371049
Päättäjät
20 yhteystietoa FunnelfeedrissäMitsuhiro Matsumoto
Outside Audit & Supervisory Board Member (Independent Auditor)
Shizuko Ueno
Director, Executive Officer, Head of Japan Business Unit and Head of Medical Affairs Division, Japan Business Unit
Yo Honma
Outside Director (Independent Director), Chairperson of the Compensation Committee
Yukiko Imazu
Outside Audit & Supervisory Board Member (Independent Auditor)
Reiko Kinoshita
Outside Director (Independent Director)
Takaaki Nishii
Outside Director (Independent Director), Chairperson of the Board
Takashi Matsumoto
Director, Senior Executive Officer, Head of Global HR, CHRO
Oliver Appelhans
Head of EU Specialty Business Unit
Naoto Tsukaguchi
Head of Global Legal & IP, General Counsel (GC)
Ken Keller
Head of Oncology Business Unit
Yasuhiro Komatsu
Outside Director (Independent Director)
Tomohiro Kodama
Corporate Officer, Head of Finance & Accounting Department, Global Corporate Planning & Management
Hiroyuki Okuzawa
Representative Director, President & CEO
Terumichi Yokoyama
Audit & Supervisory Board Member
Sunao Manabe
Representative Director, Executive Chairperson
Masako Watanabe
Outside Audit & Supervisory Board Member (Independent Auditor)
Nobuo Murakami
Head of Global Corporate Strategy, Chief Strategy Officer (CStO)
Miyuki Arai
Audit & Supervisory Board Member
Joseph Kenneth Keller
Director, Head of Oncology Business Unit
Akihiro Watanabe
Outside Director (Independent Director), Chairperson of the Nomination Committee
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
ASTRAZENECA A/S
117 työntekijätA global biopharmaceutical company focused on innovative, science-led medical research.
ASTELLAS PHARMA A/S
65 työntekijätGlobal pharmaceutical company transforming innovative science into value for patients.
BRISTOL-MYERS SQUIBB DENMARK. FILIAL AF BRISTOL-MYERS SQUIBB AB.SVERIGE
24 työntekijätGlobal biopharmaceutical company developing innovative medicines for serious diseases.
NOVARTIS HEALTHCARE A/S
88 työntekijätGlobal pharmaceutical leader developing innovative medicines to improve human health.
ABBVIE A/S
57 työntekijätA global biopharmaceutical company developing innovative medicines for serious diseases.
Selaa lisää
Kysymyksiä yrityksestä Daiichi Sankyo Nordics ApS
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo